images__1_-removebg-preview

The Encounter Is Now the Evidence: What Health Systems and Providers Must Do Right Now in Response to the CMS CY2027 Final Rule

Under the CMS CY 2027 Final Rule, diagnoses from unlinked chart reviews will no longer count toward risk score calculation. No encounter linkage, no payment eligibility.

Unlinked chart reviews are out. Retrospective diagnosis capture is structurally disadvantaged. And with 11 Stars measures removed, the clinical measures that remain carry more weight than ever before.

This guide breaks down exactly what changed — and what health systems and providers managing Medicare Advantage populations need to do right now to protect risk scores, close care gaps, and build Stars performance into the clinical workflow itself.

Inside you'll find:

  • What the unlinked chart review exclusion means for your HCC documentation strategy
  • How the new Depression Screening measure creates immediate infrastructure requirements
  • Why the remaining Stars clinical measures now carry disproportionate weight — and how to act on them at the point of care
  • A practical framework for making encounter documentation the foundation of your quality performance

View the Guide

About Inferscience

Inferscience is a physician-founded company dedicated to using the power of AI to transform risk adjustment and quality programs. Our technology seamlessly integrates into EHR workflows to surface real-time risk and care gap opportunities, improving RAF accuracy while reducing administrative burdens for clinicians.

©2026 Copyright Inferscience, Inc